These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (COVID-19). Yuan S; Chan CC; Chik KK; Tsang JO; Liang R; Cao J; Tang K; Cai JP; Ye ZW; Yin F; To KK; Chu H; Jin DY; Hung IF; Yuen KY; Chan JF Viruses; 2020 Jun; 12(6):. PubMed ID: 32532085 [TBL] [Abstract][Full Text] [Related]
5. Interferon-β-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus Infection. Clementi N; Ferrarese R; Criscuolo E; Diotti RA; Castelli M; Scagnolari C; Burioni R; Antonelli G; Clementi M; Mancini N J Infect Dis; 2020 Aug; 222(5):722-725. PubMed ID: 32559285 [TBL] [Abstract][Full Text] [Related]
6. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Caly L; Druce JD; Catton MG; Jans DA; Wagstaff KM Antiviral Res; 2020 Jun; 178():104787. PubMed ID: 32251768 [TBL] [Abstract][Full Text] [Related]
7. Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway. Ma Q; Li R; Pan W; Huang W; Liu B; Xie Y; Wang Z; Li C; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Hui M; Fu L; Yang Z Phytomedicine; 2020 Nov; 78():153296. PubMed ID: 32890913 [TBL] [Abstract][Full Text] [Related]
8. Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters. Yuan S; Wang R; Chan JF; Zhang AJ; Cheng T; Chik KK; Ye ZW; Wang S; Lee AC; Jin L; Li H; Jin DY; Yuen KY; Sun H Nat Microbiol; 2020 Nov; 5(11):1439-1448. PubMed ID: 33028965 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of SARS-CoV-2 Infection by the Cyclophilin Inhibitor Alisporivir (Debio 025). Softic L; Brillet R; Berry F; Ahnou N; Nevers Q; Morin-Dewaele M; Hamadat S; Bruscella P; Fourati S; Pawlotsky JM; Ahmed-Belkacem A Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32376613 [TBL] [Abstract][Full Text] [Related]
10. Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2. Meister TL; Brüggemann Y; Todt D; Conzelmann C; Müller JA; Groß R; Münch J; Krawczyk A; Steinmann J; Steinmann J; Pfaender S; Steinmann E J Infect Dis; 2020 Sep; 222(8):1289-1292. PubMed ID: 32726430 [TBL] [Abstract][Full Text] [Related]
11. Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients. Su HX; Yao S; Zhao WF; Li MJ; Liu J; Shang WJ; Xie H; Ke CQ; Hu HC; Gao MN; Yu KQ; Liu H; Shen JS; Tang W; Zhang LK; Xiao GF; Ni L; Wang DW; Zuo JP; Jiang HL; Bai F; Wu Y; Ye Y; Xu YC Acta Pharmacol Sin; 2020 Sep; 41(9):1167-1177. PubMed ID: 32737471 [TBL] [Abstract][Full Text] [Related]
12. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL Froggatt HM; Heaton BE; Heaton NS J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534 [TBL] [Abstract][Full Text] [Related]
13. Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 Weston S; Coleman CM; Haupt R; Logue J; Matthews K; Li Y; Reyes HM; Weiss SR; Frieman MB J Virol; 2020 Oct; 94(21):. PubMed ID: 32817221 [TBL] [Abstract][Full Text] [Related]
14. Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system. Yuan S; Chan JFW; Chik KKH; Chan CCY; Tsang JOL; Liang R; Cao J; Tang K; Chen LL; Wen K; Cai JP; Ye ZW; Lu G; Chu H; Jin DY; Yuen KY Pharmacol Res; 2020 Sep; 159():104960. PubMed ID: 32473310 [TBL] [Abstract][Full Text] [Related]
15. Anti-SARS-CoV-2 Potential of Artemisinins In Vitro. Cao R; Hu H; Li Y; Wang X; Xu M; Liu J; Zhang H; Yan Y; Zhao L; Li W; Zhang T; Xiao D; Guo X; Li Y; Yang J; Hu Z; Wang M; Zhong W ACS Infect Dis; 2020 Sep; 6(9):2524-2531. PubMed ID: 32786284 [TBL] [Abstract][Full Text] [Related]
16. Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal? Jans DA; Wagstaff KM Cells; 2020 Sep; 9(9):. PubMed ID: 32942671 [TBL] [Abstract][Full Text] [Related]
17. Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro. Choy KT; Wong AY; Kaewpreedee P; Sia SF; Chen D; Hui KPY; Chu DKW; Chan MCW; Cheung PP; Huang X; Peiris M; Yen HL Antiviral Res; 2020 Jun; 178():104786. PubMed ID: 32251767 [TBL] [Abstract][Full Text] [Related]
18. Antiviral activities of type I interferons to SARS-CoV-2 infection. Mantlo E; Bukreyeva N; Maruyama J; Paessler S; Huang C Antiviral Res; 2020 Jul; 179():104811. PubMed ID: 32360182 [TBL] [Abstract][Full Text] [Related]
19. The chemokine receptor antagonist cenicriviroc inhibits the replication of SARS-CoV-2 in vitro. Okamoto M; Toyama M; Baba M Antiviral Res; 2020 Oct; 182():104902. PubMed ID: 32739404 [TBL] [Abstract][Full Text] [Related]
20. In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect. Andreani J; Le Bideau M; Duflot I; Jardot P; Rolland C; Boxberger M; Wurtz N; Rolain JM; Colson P; La Scola B; Raoult D Microb Pathog; 2020 Aug; 145():104228. PubMed ID: 32344177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]